C. Rémuzat
Impact in
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Pharmaceutical Economics and Policy 40
- Health Systems, Economic Evaluations, Quality of Life 37
- Economic and Financial Impacts of Cancer 4
-
- Pharmaceutical studies and practices 9
- Co-authors
- Mondher Toumi (57 shared papers)Pascal Auquier (7 shared papers)Eve Hanna (2 shared papers)A. Millier (6 shared papers)Samuel Aballéa (10 shared papers)Matthias C. Angermeyer (2 shared papers)Bruno Falissard (5 shared papers)J Dorey (1 shared paper)
- Journals
- Value in Health (36 papers)Heart Failure Reviews (1 paper)BMC Psychiatry (1 paper)Targeted Oncology (1 paper)European Neuropsychopharmacology (1 paper)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
C. Rémuzat
62 papers receiving 750 citations
Peers
Comparison fields: 5 of 101
- Economics and Econometrics 254
- Immunology 156
- Physiology 89
- Biological Psychiatry 8
- Social Psychology 62
Countries citing papers authored by C. Rémuzat
This map shows the geographic impact of C. Rémuzat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rémuzat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rémuzat more than expected).
Fields of papers citing papers by C. Rémuzat
This network shows the impact of papers produced by C. Rémuzat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rémuzat. The network helps show where C. Rémuzat may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Rémuzat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 115 | |
| 2 | 2017 | 90 | |
| 3 | 2015 | 68 | |
| 4 | 2017 | 65 | |
| 5 | 2013 | 51 | |
| 6 | 2017 | 43 | |
| 7 | 2014 | 35 | |
| 8 | 2017 | 32 | |
| 9 | 2015 | 21 | |
| 10 | 2013 | 20 | |
| 11 | 2013 | 18 | |
| 12 | 2016 | 18 | |
| 13 | 2017 | 18 | |
| 14 | 2015 | 15 | |
| 15 | 2013 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2014 | 13 | |
| 18 | 2024 | 11 | |
| 19 | 2013 | 9 | |
| 20 | 2014 | 9 |
About C. Rémuzat
C. Rémuzat is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Immunology, Physiology and General Health Professions, having authored 62 papers that have together received 782 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (40 papers), Health Systems, Economic Evaluations, Quality of Life (37 papers), Pharmaceutical studies and practices (9 papers), Biosimilars and Bioanalytical Methods (8 papers), Biomedical Ethics and Regulation (6 papers), Economic and Financial Impacts of Cancer (4 papers), Intellectual Property and Patents (3 papers) and Pharmaceutical industry and healthcare (3 papers). The work is most often cited by research in Economics and Econometrics (254 citations), Immunology (156 citations), Physiology (89 citations), Biological Psychiatry (8 citations) and Social Psychology (62 citations). C. Rémuzat has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Mondher Toumi, Pascal Auquier, Eve Hanna, A. Millier, Samuel Aballéa, Matthias C. Angermeyer, Bruno Falissard, J Dorey, A. Kornfeld and C. Chouaïd. Their work appears in journals such as Value in Health, Heart Failure Reviews, BMC Psychiatry, Targeted Oncology and European Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.